• Something wrong with this record ?

Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines

J Styskala, L Styskalova, J Slouka, M Hajduch

. 2008 ; 43 (3) : 449-455.

Language English Country France

In this paper we describe the preparation of some derivatives of 1,2,4-triazino[4,5-a]benzimidazol-1-ones (5 and 6), containing additional benzimidazole ring. These compounds were prepared using coupling reactions of diazonium salts with 1,1-bis(1-ethoxycarbonyl-benzimidazol-2-yl)methane (2) to obtain unstable hydrazones 4, which readily undergo cyclization. Interestingly, the selected compounds demonstrated preferential cytotoxic activities against human carcinoma and glioma cell lines compared with leukemic cells. They showed significant activity against multidrug-resistant P-glycoprotein expressing cell lines but had less effect on multidrug-resistance protein 1 positive and topoisomerase IIalpha negative leukemias.

000      
02427naa 2200397 a 4500
001      
bmc11002988
003      
CZ-PrNML
005      
20121203121110.0
008      
110225s2008 fr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Stýskala, Jakub, $d 1972- $7 ola2005284375
245    10
$a Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines / $c J Styskala, L Styskalova, J Slouka, M Hajduch
314    __
$a Department of Organic Chemistry, Faculty of Science, Palacky University, Tr. Svobody 8, 771 46 Olomouc, Czech Republic.
520    9_
$a In this paper we describe the preparation of some derivatives of 1,2,4-triazino[4,5-a]benzimidazol-1-ones (5 and 6), containing additional benzimidazole ring. These compounds were prepared using coupling reactions of diazonium salts with 1,1-bis(1-ethoxycarbonyl-benzimidazol-2-yl)methane (2) to obtain unstable hydrazones 4, which readily undergo cyclization. Interestingly, the selected compounds demonstrated preferential cytotoxic activities against human carcinoma and glioma cell lines compared with leukemic cells. They showed significant activity against multidrug-resistant P-glycoprotein expressing cell lines but had less effect on multidrug-resistance protein 1 positive and topoisomerase IIalpha negative leukemias.
650    _2
$a protinádorové látky $x farmakologie $x chemická syntéza $x chemie $x toxicita $7 D000970
650    _2
$a benzimidazoly $x farmakologie $x chemická syntéza $x chemie $x toxicita $7 D001562
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a racionální návrh léčiv $7 D015195
650    _2
$a lidé $7 D006801
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a financování organizované $7 D005381
700    1_
$a Stýskalová, Libuše $7 xx0143798
700    1_
$a Slouka, Jan, $d 1935- $7 jn20000402233
700    1_
$a Hajdúch, Marián, $d 1969- $7 xx0050218
773    0_
$t European Journal of Medicinal Chemistry $w MED00001628 $g Roč. 43, č. 3 (2008), s. 449-455 $x 0223-5234
910    __
$a ABA008 $b x $y 1
990    __
$a 20110413113630 $b ABA008
991    __
$a 20121203121141 $b ABA008
999    __
$a ok $b bmc $g 830394 $s 694980
BAS    __
$a 3
BMC    __
$a 2008 $b 43 $c 3 $d 449-455 $i 0223-5234 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
LZP    __
$a 2011-2B/dkme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...